2-((2-(Dimethylamino)-ethyl)amino)-3-(4-methoxyphenyl)-quinazolin-4(3H)-one

ID: ALA4593788

PubChem CID: 155569694

Max Phase: Preclinical

Molecular Formula: C20H23FN4O2

Molecular Weight: 370.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-n2c(N(C)CCN(C)C)nc3cc(F)ccc3c2=O)cc1

Standard InChI:  InChI=1S/C20H23FN4O2/c1-23(2)11-12-24(3)20-22-18-13-14(21)5-10-17(18)19(26)25(20)15-6-8-16(27-4)9-7-15/h5-10,13H,11-12H2,1-4H3

Standard InChI Key:  PXEITOSPVNIWIW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   32.0094  -20.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0082  -21.3112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7163  -21.7202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7145  -20.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4231  -20.4881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4265  -21.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1389  -21.7206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8524  -21.3074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8490  -20.4822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.1321  -20.0703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1276  -19.2531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.5544  -20.0718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2637  -20.4799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9696  -20.0698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9676  -19.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2536  -18.8455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5506  -19.2579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5612  -21.7141    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6760  -18.8374    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.3002  -21.7192    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.5604  -22.5359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2651  -22.9425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9741  -22.5355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.9739  -21.7173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2646  -21.3062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3860  -19.2420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6814  -22.9448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  9 12  1  0
  8 18  1  0
 15 19  1  0
  2 20  1  0
 18 21  1  0
 18 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 19 26  1  0
 23 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4593788

    ---

Associated Targets(Human)

TRPV4 Tchem Transient receptor potential cation channel subfamily V member 4 (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.43Molecular Weight (Monoisotopic): 370.1805AlogP: 2.53#Rotatable Bonds: 6
Polar Surface Area: 50.60Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.17CX LogP: 2.92CX LogD: 2.09
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.24

References

1. Atobe M, Nagami T, Muramatsu S, Ohno T, Kitagawa M, Suzuki H, Ishiguro M, Watanabe A, Kawanishi M..  (2019)  Discovery of Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists as Regulators of Chondrogenic Differentiation: Identification of Quinazolin-4(3 H)-ones and in Vivo Studies on a Surgically Induced Rat Model of Osteoarthritis.,  62  (3): [PMID:30629441] [10.1021/acs.jmedchem.8b01615]

Source